Pages that link to "Q21245029"

The following pages link to Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention (Q21245029):

Displaying 12 items.

• Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies (Q27021082) (← links)
• Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice (Q28472590) (← links)
• Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection (Q28481276) (← links)
• The Use of Nonhuman Primate Models of HIV Infection for the Evaluation of Antiviral Strategies (Q30406868) (← links)
• Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit (Q33698152) (← links)
• Acute HIV-1 Infection (Q34185814) (← links)
• Critical issues in mucosal immunity for HIV-1 vaccine development (Q34459985) (← links)
• Universal children's day--let's improve current interventions to reduce vertical transmission of HIV now (Q34558511) (← links)
• Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia (Q34848486) (← links)
• Post-exposure prophylaxis for HIV infection (Q37866814) (← links)
• Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design (Q41338220) (← links)
• Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies (Q99622758) (← links)